Optikira
Cleveland, US · Founded 2014 · Delaware LLC
Founders & leadership
BB
Bradley BackesManager
Board
MC
Mark ChinManager
BS
Baiju ShahManager
TT
Theodore TorphyManager
Reported raises · per SEC filings
Form D private placements$8.8M disclosed across 2 rounds · 2014–2018
▶$2.7MraisedJun 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$2.7MraisedJun 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark ChinDirector
- Bradley BackesDirector
- Baiju ShahDirector
- Theodore TorphyDirector
- Offering amount
- $5M
- Amount sold
- $2.7M
- First sale
- May 2018
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$6.1MraisedJul 2018 · 7 investors · PharmaceuticalsRule 506(b)
▶$6.1MraisedJul 2018 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark ChinDirector
- Baiju ShahDirector
- Bradley BackesDirector
- Theodore TorphyDirector
- Offering amount
- $15M
- Amount sold
- $6.1M
- First sale
- Nov 2014
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Optikira raised?
- Optikira has disclosed $8.8M raised across 2 rounds.
- Where is Optikira headquartered?
- Optikira is headquartered in Cleveland, US.